Literature DB >> 16867196

Muscle dysfunction associated with chronic obstructive pulmonary disease.

Neil R MacIntyre1.   

Abstract

Skeletal-muscle (both respiratory and limb) abnormalities are common and can have profound effects in patients with chronic inflammatory states such as chronic obstructive pulmonary disease (COPD). Causes include direct inflammatory-mediator effects on muscle function, malnutrition, blood-gas abnormalities, compromised oxygen delivery from right-heart dysfunction, electrolyte imbalances, drugs, and comorbid states. In COPD patients, respiratory muscles are overloaded, which leads to increased fatigue potential, especially during exercise, when hyperinflation worsens. Interestingly, overloaded respiratory muscles develop structural changes that help them adapt to these conditions. In contrast, limb (especially lower extremity) muscles in COPD patients are underloaded as a consequence of disuse, and this leads to muscle atrophy. Treatment is aimed at optimizing lung function, nutritional repletion, aerobic exercise training, and (in certain patients) oxygen therapy. Resistive breathing training is more controversial. Lung-volume-reduction surgery may help with the hyperinflation effects and improve gas exchange and respiratory-muscle function in selected patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867196

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  10 in total

1.  Eccentric exercise in patients with chronic health conditions: a systematic review.

Authors:  Marc Roig; Babak Shadgan; W Darlene Reid
Journal:  Physiother Can       Date:  2008-10-10       Impact factor: 1.037

2.  Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study.

Authors:  Paolo J C Biselli; Jason P Kirkness; Ludger Grote; Kathrin Fricke; Alan R Schwartz; Philip Smith; Hartmut Schneider
Journal:  J Appl Physiol (1985)       Date:  2016-11-04

3.  Pulmonary Rehabilitation Reduces Emergency Admission and Hospitalization Rates of Patients with Chronic Respiratory Diseases.

Authors:  İpek Özmen; Elif Yıldırım; Murat Öztürk; Birsen Ocaklı; Reyhan Yıldız; Rüya Aydın; Meral Karakış; Özgür Yılmaz; Emine Aksoy
Journal:  Turk Thorac J       Date:  2018-09-13

4.  Impact of frailty in elderly patients with moderate to severe asthma.

Authors:  Ricardo G Figueiredo; Gabriela P Pinheiro; Vanessa Arata; Maisa F M Leal; Cinthia V N Santana; Taciana L Tiraboschi; José Bessa Junior; Álvaro A Cruz
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

5.  Consilience in sarcopenia of cirrhosis.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

6.  Differences in subjective and objective respiratory parameters in patients with chronic obstructive pulmonary disease with and without pain.

Authors:  Signe Berit Bentsen; Tone Rustøen; Christine Miaskowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-02-28

7.  Brief Report: Association Between Pain, Pulmonary Function, and Respiratory Symptoms in People With HIV.

Authors:  Deepti G Singhvi; Mehdi Nouraie; Cathy Kessinger; Deborah K McMahon; Renee Weinman; Kristina Crothers; Laurence Huang; Jessica Bon; Alison Morris; Jessica Merlin
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-15       Impact factor: 3.771

8.  Content Validity of the Comprehensive ICF Core Set for Chronic Obstructive Pulmonary Diseases: An International Delphi Survey.

Authors:  Andrea Jobst; Inge Kirchberger; Alarcos Cieza; Gerold Stucki; Armin Stucki
Journal:  Open Respir Med J       Date:  2013-04-05

9.  Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients.

Authors:  Barakat Shahin; Michele Germain; Alzahouri Kazem; Guy Annat
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Respiratory electrophysiologic studies in chronic obstructive pulmonary disease.

Authors:  Yu Wang; Na Liu; Zhecheng Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.